Brief: Intensity Therapeutics Announces Two Presentations At The Upcoming 2025 San Antonio Breast Cancer Symposium
Intensity Therapeutics Q3 net loss narrows to $2.7 mln
Brief: Intensity Therapeutics Q3 Operating Income USD -2.733 Million
U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna
Intensity Therapeutics shares more than double on promising cancer trial data
U.S. STOCKS ON THE MOVE-Wolfspeed, Carvana, Metsera
Intensity Therapeutics shares more than double on promising cancer trial data
Brief: Intensity Therapeutics: INVINCIBLE-4 TNBC Trial Update
Brief: Intensity Therapeutics Raises $6.6 Million From At The Market Offering (ATM) Stock Sales
Brief: Intensity Therapeutics Inc Int230-6 Achieved 100% Complete Response Rate In Preclinical Models Of Malignant Peripheral Nerve Sheath Tumors
Brief: Intensity Therapeutics, Inc. Announces That Int230-6 Achieved 100% Complete Response Rate In Preclinical Models Of Malignant Peripheral Nerve Sheath Tumors (Mpnst)
Brief: Intensity Therapeutics Prices Public Offering Of 6,675,000 Shares At $0.30 Per Share
Brief: Intensity Therapeutics Announces Proposed Public Offering Of Common Stock
Brief: Intensity Therapeutics Announces Patients Receiving INT230-6 Prior To Start Of Standard-Of-Care May Achieve High Levels Of Tumor Necrosis In Ongoing Randomized Controlled Phase 2 Invincible-4 Study
Brief: Intensity Therapeutics to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy
Brief: Intensity Therapeutics Q1 Basic EPS USD -0.22
Brief: Intensity Therapeutics Announces Pricing Of $3 Million Registered Direct Offering And Concurrent Private Placement
Brief: Intensity Therapeutics, Inc. And The Swiss Group For Clinical Cancer Research SAKK Announce The First Patient Dosed In The Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 / SAKK 66/22)
Brief: Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase 3 Study (INVINCIBLE-3) in Metastatic Soft Tissue Sarcoma